European journal of clinical pharmacology
-
Eur. J. Clin. Pharmacol. · Aug 2007
Randomized Controlled Trial Multicenter Study Comparative StudyComparison of intravenous dexketoprofen and dipyrone in acute renal colic.
The aim of this study was to assess the efficacy and safety of a single intravenous (i.v.) bolus of dexketoprofen trometamol compared with an i.v. infusion of dipyrone in patients with moderate to severe pain due to renal colic. ⋯ Dexketoprofen 50 mg administered as a single i.v. bolus was effective for the relief of moderate to severe pain in patients with renal colic, with a good safety profile and efficacy similar to i.v. dipyrone 2 g. Dexketoprofen produced analgesia that was faster in onset.
-
Eur. J. Clin. Pharmacol. · Aug 2007
Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.
The use of triptans (5-HT agonists) in the treatment of migraine is associated with a potential increasing risk of cardiovascular events and raises the question of the relationship between overuse and the occurrence of ischemic events. ⋯ The proportion of patients showing an overuse of triptans (more than 15 DDD for 30 days) reached 12% in this cohort of new users of triptans. However, we did not find any relationship between the overuse of triptans and cardiac outcomes. This study also shows that some patients with cardiovascular risk factors are actually treated by triptans. These patients are more likely to present a cardiac outcome potentially related to an ischemic event after the introduction of triptan.
-
The aim of this study was to assess the analgesic treatment and the prevalence of pain in patients treated with analgesics in hospitals. ⋯ Although analgesic use is high in the hospital settings, adherence to the principles and recommendations of pain guidelines is low, and pain is usually common in patients treated with analgesics. These results once again emphasise the need to improve analgesic use and pain management in hospitals.
-
Eur. J. Clin. Pharmacol. · Apr 2007
Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants.
To study the risk for congenital malformations among infants whose mothers used anti-asthmatic drugs during pregnancy. ⋯ Maternal asthma and use of anti-asthmatic drugs carry no major risk for congenital malformations in the offspring, but a slight teratogenic effect cannot be excluded. It may be due to asthma, and arguments for a stronger effect of inhaled corticosteroids than of other anti-asthmatics are weak.